228 related articles for article (PubMed ID: 7590470)
1. A retrospective study of tamoxifen and endometrial cancer in breast cancer patients.
Robinson DC; Bloss JD; Schiano MA
Gynecol Oncol; 1995 Nov; 59(2):186-90. PubMed ID: 7590470
[TBL] [Abstract][Full Text] [Related]
2. The incidence of subsequent endometrial carcinoma with tamoxifen use in patients with primary breast carcinoma.
Katase K; Sugiyama Y; Hasumi K; Yoshimoto M; Kasumi F
Cancer; 1998 May; 82(9):1698-703. PubMed ID: 9576291
[TBL] [Abstract][Full Text] [Related]
3. Gynecologic tumors in tamoxifen-treated women with breast cancer.
Seoud MA; Johnson J; Weed JC
Obstet Gynecol; 1993 Aug; 82(2):165-9. PubMed ID: 8393156
[TBL] [Abstract][Full Text] [Related]
4. Tamoxifen treatment for breast cancer and risk of endometrial cancer: a case-control study.
Swerdlow AJ; Jones ME;
J Natl Cancer Inst; 2005 Mar; 97(5):375-84. PubMed ID: 15741574
[TBL] [Abstract][Full Text] [Related]
5. Endometrial cancer after tamoxifen treatment: a descriptive study of 25 breast cancer patients who subsequently developed endometrial cancer.
Peters-Engl C; Medl M; Danmayr E; Mirau M; Alth G; Leodolter S
Anticancer Res; 1996; 16(5B):3241-6. PubMed ID: 8920798
[TBL] [Abstract][Full Text] [Related]
6. Comparison of endometrial changes among symptomatic tamoxifen-treated and nontreated premenopausal and postmenopausal breast cancer patients.
Cheng WF; Lin HH; Torng PL; Huang SC
Gynecol Oncol; 1997 Aug; 66(2):233-7. PubMed ID: 9264568
[TBL] [Abstract][Full Text] [Related]
7. Endometrial carcinoma associated with breast carcinoma: low incidence with tamoxifen use.
Cuenca RE; Giachino J; Arredondo MA; Hempling R; Edge SB
Cancer; 1996 May; 77(10):2058-63. PubMed ID: 8640670
[TBL] [Abstract][Full Text] [Related]
8. Detection of endometrial cancer in asymptomatic postmenopausal breast cancer patient treated with tamoxifen: a case report.
Sinawat S; Chiyabutra T; Kleabkaew P
J Med Assoc Thai; 2001 Jul; 84(7):1033-6. PubMed ID: 11759963
[TBL] [Abstract][Full Text] [Related]
9. Tamoxifen mediated human endometrial carcinogenesis may not involve estrogenic pathways: a preliminary note.
Kuwashima Y; Kurosumi M; Kobayashi Y; Tanuma J; Suemasu K; Higashi Y; Kasamatsu T; Shiromizu K; Matsuzawa M; Kishi K
Anticancer Res; 1996; 16(5A):2993-6. PubMed ID: 8917418
[TBL] [Abstract][Full Text] [Related]
10. Does tamoxifen use affect prognosis in breast cancer patients who develop endometrial cancer?
Slomovitz BM; Sun CC; Ramirez PT; Bodurka DC; Diaz P; Lu KH
Obstet Gynecol; 2004 Aug; 104(2):255-60. PubMed ID: 15291996
[TBL] [Abstract][Full Text] [Related]
11. Is tamoxifen associated with high-risk endometrial carcinomas? A retrospective case series of 196 women with endometrial cancer.
Rieck GC; Freites ON; Williams S
J Obstet Gynaecol; 2005 Jan; 25(1):39-41. PubMed ID: 16147692
[TBL] [Abstract][Full Text] [Related]
12. [Clinicopathological features of endometrial carcinoma in tamoxifen- and toremifene-treated breast cancer patients].
Otsuka I; Takahashi S; O'uchi K; Akimoto N; Hanari K; Ogaki Y; Enatsu YH; Takigawa A; Takaya H; Tanaka A; Kaseki H; Yamada T
Gan To Kagaku Ryoho; 2010 Feb; 37(2):279-83. PubMed ID: 20154485
[TBL] [Abstract][Full Text] [Related]
13. Malignant endometrial polyps in postmenopausal breast cancer tamoxifen-treated patients.
Cohen I; Bernheim J; Azaria R; Tepper R; Sharony R; Beyth Y
Gynecol Oncol; 1999 Oct; 75(1):136-41. PubMed ID: 10502440
[TBL] [Abstract][Full Text] [Related]
14. Endometrial carcinoma following treatment for breast carcinoma in a Nigerian female. A case report and review of the literature.
Abudu EK; Musa O; Adefuye PO; Abdul Kareem FB; Agboola AO; Banjo AA
Niger Postgrad Med J; 2007 Dec; 14(4):355-7. PubMed ID: 18163149
[TBL] [Abstract][Full Text] [Related]
15. The nature of tamoxifen action in the control of female breast cancer.
Kodama M; Kodama T
In Vivo; 2001; 15(4):319-25. PubMed ID: 11695224
[TBL] [Abstract][Full Text] [Related]
16. Secretory endometrial adenocarcinoma in a tamoxifen user with breast cancer after menopause.
Wu CJ; Peng YJ; Yu MH; Chen CH
Taiwan J Obstet Gynecol; 2007 Mar; 46(1):88-90. PubMed ID: 17389201
[No Abstract] [Full Text] [Related]
17. Clinicopathologic study of 56 patients with endometrial cancer during or after adjuvant tamoxifen use for their breast cancers.
Hachisuga T; Saito T; Kigawa J; Ohwada M; Yamazawa K; Yasue A; Iwasaka T; Sugiyama T; Kita T; Nagai N
Gynecol Oncol; 2004 Oct; 95(1):139-44. PubMed ID: 15385123
[TBL] [Abstract][Full Text] [Related]
18. Endometrial pathology at dilatation and curettage in breast cancer patients: comparison of tamoxifen users and nonusers.
Gibson LE; Barakat RR; Venkatraman ES; Hoskins WJ
Cancer J Sci Am; 1996; 2(1):35-8. PubMed ID: 9166496
[TBL] [Abstract][Full Text] [Related]
19. [MR Imaging of the pelvis in the diagnosis of the endometrium in breast cancer patients in tamoxifen therapy].
Hauth E; Libera H; Kimmig R; Forsting M
Rofo; 2006 Mar; 178(3):316-23. PubMed ID: 16508840
[TBL] [Abstract][Full Text] [Related]
20. Iatrogenic endometrial megapolyps in women with breast carcinoma.
Berezowsky J; Chalvardjian A; Murray D
Obstet Gynecol; 1994 Oct; 84(4 Pt 2):727-30. PubMed ID: 9205466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]